Article
AbbVie to buy Cerevel Therapeutics in $8.7 billion all-cash deal
Rating:
0.0
Views:
27
Likes:
1
Library:
1
AbbVie Inc. said late Wednesday it has agreed to buy Cerevel Therapeutics Holdings Inc. for $8.7 billion, saying that Cerevel's "robust" neuroscience...
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value